Roche Secures Promising Bowel Disease Therapy —Which Could Help Treat Crohn’s—In $7.1 Billion Telavant Deal

The Swiss pharma giant said it will begin late-stage trials on the experimental antibody therapy “as soon as possible” to help bring it to patients suffering from inflammatory bowel disease.

Source: Forbes.com Healthcare News - October 23, 2023 Category: Pharmaceuticals Authors: Robert Hart, Forbes Staff Tags: Business /business Innovation /innovation Healthcare /healthcare Breaking breaking-news topline Source Type: news